New drug ZE74-0282 tested in healthy people for first time
Knowledge-focused
Not yet recruiting
This early-stage study tests a new drug called ZE74-0282 in 40 healthy adults aged 18 to 55. The main goal is to check its safety and how the body handles it, not to treat any disease. Participants receive either the drug or a placebo, and researchers monitor side effects and dru…
Phase: PHASE1 • Sponsor: Eilean Therapeutics AU Pty Ltd • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC